ConcoursCorrect

The concourse for today's immunotherapy is a spectacular shiny showroom of the sleekest and most advanced biotechnology in the 21st century.  We're not finished yet, and this project will support fine tuning these important regimens based on patient reactivity.  

ConcoursCorrect:

• A multi-source, retrospective deep-dive data analysis initiative to understand, predict, and stratify risk for Immune Checkpoint Inhibitor related irAEs across tumor types. 
• Integrates EHR and claims data (Open and Closed) to investigate symptom signals, biomarkers, and regimen-level predictors of irAE expression in cancer patients. 
• Leverages a single or multi-center data source(s) to establish patient and/or prescriber cohort, with linkage across the US healthcare ecosystem for full comprehensive patient journey
• Includes collaboration with leading clinicians and operational co-leads to guide translational relevance. 

If you have questions about our research or are interested in partnering with us, please don't hesitate to get in touch. We'd love to hear from you.